Applicants should hold a PhD, MD, or equivalent doctoral degree in molecular and cellular biology, cancer biology, oncology, or a related field, with postdoctoral experience in cancer biology or translational oncology. Candidates should have expertise relevant to brain metastasis, tumor heterogeneity, oncogene-driven lung cancer, and/or therapeutic resistance, particularly in ALK fusion-positive lung cancer. Applicants should demonstrate scholarly productivity through peer-reviewed publications, presentations, and collaborative research contributions, as well as experience with molecular biology techniques, tumor models, sequencing- or microscopy-based analyses, and scientific writing. Strong communication, critical thinking, project leadership, and teamwork skills are required.